China NT Pharma Group Co., Ltd. (HK:1011) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
China NT Pharma Group Co., Ltd. has announced the termination of a significant acquisition, after having already issued shares to consultants for project milestones in drug development and clinical trials. Despite the project’s early termination, lock-up arrangements have been set to protect the company’s interests. Furthermore, the company has engaged consultants for an additional three years to enhance their orthopedic product line, amidst challenges such as changes in regulations and unmet assumptions affecting the valuation of intangible assets.
For further insights into HK:1011 stock, check out TipRanks’ Stock Analysis page.